Pharma Journalist 9027 posts 0 comments

Novavax, Inc. announced that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with a vaccine efficacy of 89.3%, in its Phase 3 clinical trial…
Read More...

Valneva SE, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need, announced it has commenced production of its inactivated,…
Read More...

Eli Lilly and Company and Asahi Kasei Pharma Corporation announced a license agreement whereby Lilly will acquire the exclusive rights for AK1780 from Asahi Kasei Pharma. AK1780 is an…
Read More...

Hoth Therapeutics, Inc. announced extending a research collaboration agreement with Weill Cornell Medicine to continue investigating the therapeutic mechanism of action and safety of…
Read More...

Chronic and rare kidney disease drug development has been heating up as stakeholders bustle to deliver benefits beyond SGLT2s.  Already in January 2021, Bayer and AstraZeneca have been…
Read More...

Sanofi and BioNTech have entered into an agreement under which Sanofi will support manufacturing and supply of BioNTech’s COVID-19 vaccine which is being co-developed with Pfizer.…
Read More...

Following the FDA’s approval of 12 personalised medicines and 7 diagnostics in 2019, then a record number of precision oncology drugs in H1 2020, demand is high for Dx-enabled therapies…
Read More...

With the global oligonucleotide therapeutics market forecasted to climb to a record value of 7 billion dollars in the next 3 years, a rapidly increasing volume of FDA approvals and…
Read More...

AI Driven Drug Repositioning and Repurposing Summit taking place April 20-21, is an exciting online event which shines a light on the benefits of AI tools in drug repurposing and helps…
Read More...

Join our ground-breaking new conference dedicated to drive forward the development of effective therapies for chronic fibrosing ILDs. The ILD Summit takes place this April 27-29,…
Read More...